Advertisement

Topics

Biodel Inc. Company Profile

22:56 EST 23rd November 2017 | BioPortfolio

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes. Biodel's product candidates are developed using VIAdelTM technology, which reformulates existing FDA-approved peptide drugs. Biodel's new drug application for its most advanced product candidate, VIAject®, has been accepted for review by the FDA with a Prescription Drug User Fee Act action date of October 30, 2010. Earlier-stage product candidates include VIAtab™, a sublingual tablet formulation of insulin, a line of basal insulins, and a stabilized formulation of glucagon. For further information regarding Biodel, please visit the company's website at www.biodel.com.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Biodel, Inc.

Biodel is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders such as diabetes. Biodel's produc...

Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes. Biodel's product candidates are develo...

More Information about "Biodel Inc." on BioPortfolio

We have published hundreds of Biodel Inc. news stories on BioPortfolio along with dozens of Biodel Inc. Clinical Trials and PubMed Articles about Biodel Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biodel Inc. Companies in our database. You can also find out about relevant Biodel Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record